Control of Lipids at Baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial-Reference-Cited by-同舟云学术

Control of Lipids at Baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

Published:2009-01 Issue:1 Volume:12 Page:9-18
ISSN:1520-037X
Container-title:Preventive Cardiology
language:en
Short-container-title:

Author:

Pambianco Georgia,Lombardero Manuel,Bittner Vera,Forker Alan,Kennedy Frank,Krishnaswami Ashok,Mooradian Arshag D.,Pop-Busui Rodica,Rana Jamal S.,Rodriguez Annabelle,Steffes Michael,Orchard Trevor J.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Public Health, Environmental and Occupational Health

Reference32 articles.

1. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030;Wild;Diabetes Care.,2004

2. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction;Haffner;New Eng J Med.,1998

3. Impact of diabetes and coronary artery disease in women and men;Lee;Diabetes Care.,2000

4. Diabetic dyslipidaemia: treatment implications;Betteridge;J Intern Med.,1994

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization;Journal of the American College of Cardiology;2020-11

2. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease;Cochrane Database of Systematic Reviews;2018-09-24

3. Understanding Gender Differences in Statin Use among Elderly Medicare Beneficiaries;Drugs & Aging;2012-11-17

4. Modifiable factors for reducing the gender difference in lipid control;Clinical Lipidology;2012-08-01

5. Triglycerides and Cardiovascular Disease;Circulation;2011-05-24